METHOFILL®, is an EFG prefilled syringe injectable methotrexate with a safety system and a concentration of 50mg/ml.
METHOFILL® is indicated for the treatment of:
There are 10 presentations adapted to each type of patient according to indication.
Methofill® 7,5 mg/0,15 ml – Methofill 12,5 mg/0,25 ml – Methofill 15 mg/0,30 ml – Methofill 17,5 mg/0,35 ml – Methofill® 20 mg/0,40 ml – Methofill 22,5 mg/0,45 ml – Methofill 25 mg/0,50 ml – Methofill 27,5 mg/0,55 ml – Methofill® 30 mg/0,60 ml
All presentations are available in pack of 1 syringe and pack of 4 syringes.
Ownership: Accord Healthcare S.L.U.
Marketed by: Marketed and distributed in Spain by Laboratorios Rubió as a local representative
